×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INDP – indaptus therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INDP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/12
08:00 am
indp
Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/11
08:00 am
indp
Indaptus Therapeutics’ Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in Immunology
Low
Report
Indaptus Therapeutics’ Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in Immunology
11/7
08:00 am
indp
Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting
Low
Report
Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting
10/23
08:00 am
indp
Indaptus Therapeutics to Present at Two Upcoming Investor Conferences
Medium
Report
Indaptus Therapeutics to Present at Two Upcoming Investor Conferences
10/22
08:00 am
indp
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
High
Report
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
10/16
08:31 am
indp
Indaptus Therapeutics, Inc. (NASDAQ: INDP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Indaptus Therapeutics, Inc. (NASDAQ: INDP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
10/15
08:00 am
indp
Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data
High
Report
Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data
10/10
08:00 am
indp
Indaptus Therapeutics Founder and Chief Scientific Officer to Speak on Lumanity Webinar about the Future of Innate Immunity in Cancer Immunotherapy
High
Report
Indaptus Therapeutics Founder and Chief Scientific Officer to Speak on Lumanity Webinar about the Future of Innate Immunity in Cancer Immunotherapy
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
09:42 am
indp
Form 10-Q Indaptus Therapeutics, For: Sep 30
Low
Report
Form 10-Q Indaptus Therapeutics, For: Sep 30
11/12
09:26 am
indp
Form 8-K Indaptus Therapeutics, For: Nov 12
Medium
Report
Form 8-K Indaptus Therapeutics, For: Nov 12
10/22
08:05 am
indp
Form 8-K Indaptus Therapeutics, For: Oct 17
High
Report
Form 8-K Indaptus Therapeutics, For: Oct 17
10/10
04:10 pm
indp
Form SC 13D Indaptus Therapeutics, Filed by: Meckler Jeffrey A
Medium
Report
Form SC 13D Indaptus Therapeutics, Filed by: Meckler Jeffrey A
10/10
04:05 pm
indp
Form 4 Indaptus Therapeutics, For: Oct 09 Filed by: Waltzman Roger J.
Medium
Report
Form 4 Indaptus Therapeutics, For: Oct 09 Filed by: Waltzman Roger J.
10/10
04:05 pm
indp
Form 4 Indaptus Therapeutics, For: Oct 09 Filed by: Meckler Jeffrey A
Medium
Report
Form 4 Indaptus Therapeutics, For: Oct 09 Filed by: Meckler Jeffrey A
10/10
04:05 pm
indp
Form 4 Indaptus Therapeutics, For: Oct 09 Filed by: Sassi Nir
Medium
Report
Form 4 Indaptus Therapeutics, For: Oct 09 Filed by: Sassi Nir
10/10
04:05 pm
indp
Form 4 Indaptus Therapeutics, For: Oct 09 Filed by: Linscott Walt Addison
Medium
Report
Form 4 Indaptus Therapeutics, For: Oct 09 Filed by: Linscott Walt Addison
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: